Secretion of IL-6 and IL-8 in Caco-2 cells treated with cytokines and α-MSH. by Judit Váradi (507449)

Immunohistochemical staining and analysis of NF-κB activation in cytokine- and α-MSH-treated Caco-2 cells. by Judit Váradi (507449)

Svaldi et al.’s “High Load” and “Low Load” groups from a soccer season (High Load percentiles: 25th = 4515 g, 50th = 5615 g, 75th = 12313 g; Low Load percentiles: 25th = 2425 g, 50... by Joshua Auger (9530081)

“…<p>Post-season adjustments to the High Load group: 19.7% reduction from decreasing inflation pressure from 1.10 bar (16 psi) to 0.55 bar (8 psi), 7.1% reduction from downsizing a size 5, 0.55 bar (8 psi) ball to size 4.5, 0.55 bar (8 psi) ball (<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0240162#pone.0240162.t003" target="_blank">Table 3</a>), and a 20% reduction in number of hits based on average PLA per hit (Adjusted High Load percentiles: 25th = 2463 g, 50th = 3063 g, 75th = 6718 g).…”

The effect of different concentrations of α-MSH on the electrical resistance of cytokine treated Caco-2 monolayers. by Judit Váradi (507449)

Image2_First-Line ICI Monotherapies for Advanced Non-small-cell Lung Cancer Patients With PD-L1 of at Least 50%: A Cost-Effectiveness Analysis.TIF by Qiao Liu (346535)

“…</p><p>Conclusion: For advanced NSCLC patients with PD-L1 of at least 50%, cemiplimab was a cost-effective option compared with pembrolizumab and a dominant alternative against atezolizumab. …”

Image1_First-Line ICI Monotherapies for Advanced Non-small-cell Lung Cancer Patients With PD-L1 of at Least 50%: A Cost-Effectiveness Analysis.TIFF by Qiao Liu (346535)

“…</p><p>Conclusion: For advanced NSCLC patients with PD-L1 of at least 50%, cemiplimab was a cost-effective option compared with pembrolizumab and a dominant alternative against atezolizumab. …”

Image3_First-Line ICI Monotherapies for Advanced Non-small-cell Lung Cancer Patients With PD-L1 of at Least 50%: A Cost-Effectiveness Analysis.TIF by Qiao Liu (346535)

“…</p><p>Conclusion: For advanced NSCLC patients with PD-L1 of at least 50%, cemiplimab was a cost-effective option compared with pembrolizumab and a dominant alternative against atezolizumab. …”

Age-adjusted Hazard Ratios (HR) for a hip fracture, lowest quartile of BMD compared to the higher three quartiles of BMD, measured with DXL of the calcaneus or DXA of the femoral n... by Hans Lundin (800973)

Current flow routes of the developed FBRC converter. by M. Zakir Hossain (6033752)

Potent Sensitisation of Cancer Cells to Anticancer Drugs by a Quadruple Mutant of the Human Deoxycytidine Kinase by Safiatou T. Coulibaly (816058)

“…Importantly, a remarkable effect is also observed in treatments with the anticancer compound cytarabine (AraC), for which a 10,000 fold decrease in IC50 occurred. …”

Near-infrared spectroscopy (NIRS)-obtained muscle oxygenation data at baseline, 50 W, and the ventilatory threshold (VT). by Austin K. Ederer (848527)

Effect of OP2113 on infarct size. by Dominique Detaille (3768979)

Emergence of Dynamic Instability by Hybridizing Synthetic Self-Assembled Dipeptide Fibers with Surfactant Micelles by Shogo Torigoe (13221476)

Effect of LUX and IB on anti-IgM-induced BTK activation in SU-DHL-6 cells. by Himangshu Sonowal (14761882)

Fluorescent intensity at 520 nm (RNase A/B) and 556 nm (DNase I) versus time for nucleases in DI water lysed with Lyse-It at 30% and 50% power for varying time. by Tonya M. Santaus (5559077)

Flexible Reaction Pocket on Bulky Diphosphine–Ir Complex Controls Regioselectivity in <i>para</i>-Selective C–H Borylation of Arenes by Brandon E. Haines (1312221)

“…It is shown that an increase in the steric bulk of the ligand by introducing bulkier 3,5-substituents to the phenyl rings of the diarylphosphino groups of <b>L1</b> <i>decreases</i> the <i>para</i>-selectivity. This computational prediction was validated by experiments on C–H borylation of trimethyl­(phenyl)­silane by using the 3,5-di-<i>tert</i>-butylphenyl analogue of MeO-BIPHEP (<b>L3</b>) as a diphosphine ligand that showed a <i>decrease</i> in <i>para</i>/<i>meta</i> ratio from 88:12 (<b>L1</b>) to 50:50 (<b>L3</b>). …”

Effect of LUX on BLNK-BTK interactions in JeKo-1 and RL cells. by Himangshu Sonowal (14761882)

Effect of LUX and IB on anti-IgM-induced activation of SYK in SU-DHL-6 cells. by Himangshu Sonowal (14761882)

Effect of LUX and IB on anti-IgM-induced phosphorylation of LYN in JeKo-1 and RL cells. by Himangshu Sonowal (14761882)

Effect of LUX and IB on anti-IgM-induced activation of BLNK and BLNK-BTK interactions in SU-DHL-6 cells. by Himangshu Sonowal (14761882)